atropine has been researched along with Bile Duct Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, YJ; Lu, Y; Yao, RY; Zhang, BY | 1 |
Norton, RA; Paul, RE; Robbins, AH; Schimmel, EM; Sugarman, HJ; Tomas, JG | 1 |
2 other study(ies) available for atropine and Bile Duct Cancer
Article | Year |
---|---|
Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.
Topics: Atropine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chi-Square Distribution; Cholangiocarcinoma; Dose-Response Relationship, Drug; Humans; Muscarinic Agonists; Muscarinic Antagonists; Neoplasm Invasiveness; Peripheral Nerves; Pilocarpine; Receptor, Muscarinic M3 | 2012 |
Detection of malignant disease by peroral retrograde pancreatico-biliary ductography.
Topics: Adult; Aged; Atropine; Bile Duct Neoplasms; Cholangiography; Cholelithiasis; Cholestasis; Diatrizoate; Diazepam; Gallstones; Humans; Male; Middle Aged; Pancreatic Ducts; Pancreatic Neoplasms; Pancreatitis; Premedication; Propantheline; Silicones | 1973 |